Capella Bioscience Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Capella Bioscience Ltd
- Target Recruit Count
- 56
- Registration Number
- NCT05323110
- Locations
- 🇬🇧
HMR, London, United Kingdom
News
No news found